BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8777792)

  • 1. Trazodone: a non-hormonal alternative for neurovegetative climacteric symptoms.
    Pansini F; Albertazzi P; Bonaccorsi G; Zanotti L; Porto S; Dossi L; Campobasso C; Mollica G
    Clin Exp Obstet Gynecol; 1995; 22(4):341-4. PubMed ID: 8777792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The menopausal transition: a dynamic approach to the pathogenesis of neurovegetative complaints.
    Pansini F; Albertazzi P; Bonaccorsi G; Calisesi M; Campobasso C; Zanotti L; Bagni B; Mollica G
    Eur J Obstet Gynecol Reprod Biol; 1994 Nov; 57(2):103-9. PubMed ID: 7859901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
    Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
    Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serotonin neurotrasmission and treatment options for depression].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):174-177. PubMed ID: 29265105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survey on characteristics of menopause of Chinese women with the age of 40-60 years at gynecological clinic from 14 hospitals].
    Chen R; Yu Q; Xu KH; Xie MQ; Lei XM; Ren ML; Ruan XY; Ding Y; Fu SX; Yang X; Lin Y; Wang HL; Wu YY; Zhang SF; Guo XT
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):723-7. PubMed ID: 24406126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trazodone Contramid® in clinical practice: personalizing antidepressant intervention].
    Fagiolini A; Amodeo G; Goracci A; Blardi P
    Riv Psichiatr; 2016; 51(4):123-128. PubMed ID: 27727261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV; Rozova A; Gossen ER; Gibertini M
    Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current treatment of depression and agitation in the elderly -- clinical use of trazodone].
    Osváth P
    Neuropsychopharmacol Hung; 2013 Sep; 15(3):147-55. PubMed ID: 24108179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Climacteric syndrome: comparison of several secondary therapies].
    Bianco V; Colombo A; Tassan Simonat P
    Ann Ostet Ginecol Med Perinat; 1991; 112(1):54-60. PubMed ID: 1929099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trazodone--its multifunctional mechanism of action and clinical use].
    Frecska E
    Neuropsychopharmacol Hung; 2010 Dec; 12(4):477-82. PubMed ID: 21220793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice.
    Cuomo A; Ballerini A; Bruni AC; Decina P; Di Sciascio G; Fiorentini A; Scaglione F; Vampini C; Fagiolini A
    Riv Psichiatr; 2019; 54(4):137-149. PubMed ID: 31379379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kami-shoyo-san, Kampo (Japanese traditional medicine), is effective for climacteric syndrome, especially in hormone-replacement-therapy-resistant patients who strongly complain of psychological symptoms.
    Hidaka T; Yonezawa R; Saito S
    J Obstet Gynaecol Res; 2013 Jan; 39(1):223-8. PubMed ID: 22765925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment and treatment of hot flushes and menopausal mood disturbance.
    Joffe H; Soares CN; Cohen LS
    Psychiatr Clin North Am; 2003 Sep; 26(3):563-80. PubMed ID: 14563098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trazodone in the elderly: risk of extrapyramidal acute events.
    Sotto Mayor J; Pacheco AP; Esperança S; Oliveira e Silva A
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26174731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does trazodone have a role in palliating symptoms?
    Davis MP
    Support Care Cancer; 2007 Feb; 15(2):221-4. PubMed ID: 17131134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insomnia treatment in the third trimester of pregnancy reduces postpartum depression symptoms: a randomized clinical trial.
    Khazaie H; Ghadami MR; Knight DC; Emamian F; Tahmasian M
    Psychiatry Res; 2013 Dec; 210(3):901-5. PubMed ID: 23993464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of trazodone in the treatment of insomnia].
    Gałecki P; Florkowski A; Talarowska M
    Pol Merkur Lekarski; 2010 Jun; 28(168):509-12. PubMed ID: 20642116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot study.
    De Wit S; Cremers L; Hirsch D; Zulian C; Clumeck N; Kormoss N
    J Int Med Res; 1999; 27(5):223-32. PubMed ID: 10689628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40-60 years.
    Lam PM; Leung TN; Haines C; Chung TK
    Maturitas; 2003 Jun; 45(2):99-107. PubMed ID: 12787968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period.
    Hagen C; Christensen MS; Christiansen C; Stocklund KE; Transbøl I
    Acta Obstet Gynecol Scand; 1982; 61(3):237-41. PubMed ID: 6812385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.